tumor immunity Flashcards

1
Q

characteristics of cancer cells

A
  • stimulate their own growth
  • ignore growth-inhibiting signals
  • evade apoptosis
  • develop a blood supply: angiogenesis
  • metastasis
  • replicate continuously
  • evade immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define tumor

A

(neoplasm)- cells growing abnormally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define metastasis

A

spreading of cancer cells to distant sites, focus of new growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define malignant transformation

A

the process through which a cell becomes able to form cancer
- this involves accumulation of multiple mutations in genes that regulate cell division and cell survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

difference between benign & malignant

A

benign- adenoma
- contained by fibrous connective tissue
- localized and limited in size

malignant- adenocarcinoma
- not limited by capsule, invasive, can break through basal laminae & invade adjacent tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

common sites for tumor development

A
  • sites of lots of cellular turniver
  • bone marrow, lymph glands, lungs, reproductive organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

causes of cancer

A

1- environmental- often referred to as mutagens, carcinogens, oncogenic viruses
2- genetic- mutations in certain genes
. BRCA1/BRCA2- mutant forms of these tumor suppressor genes increase risk of breast and ovarian cancer by five fold (60% compared to normal 12%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

genes whose product positively regulate cell division & function normally in normal cells

A

proto-oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mutated versions of proto-oncogenes that contribute to malignant transformation

A

oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

encode proteins that prevent unwanted proliferation of mutant cells

A

tumor suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tumor suppressor gene- over 50% of of human tumors have a mutation in this gene

A

p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

many human tumors are caused by viruses

A

1- DNA viruses:
. Papillomavirus- warts (benign), carcinoma uterus
. Hepatitis B virus- liver cancer
. Epstein-barr virus- Burkitt’s lymphoma
2- RNA viruses:
. HTLV-1- adult T-cell leukemia/lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

name 3 cancers of the immune system

A

1- leukemia- cancer of immune system cells
2- lymphoma- involving solid lymphoid tumors
3- myeloma- involving bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how can the immune system recognize tumors as dangerous and target them for removal?

A
  • tumor antigens
  • cells that are malignantly transformed have genotypic differences that distinguish them from healthy cells
  • antigens present on tumors cells, but not normal cells are called tumor-specific antigens
  • antigens present on tumors but also normal cells ( at lower expression levels) are called tumor associated antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe tumor specific antigens

A
  • present on tumor cells but not on normal cells (certain p53, ras, and B-catenin variants)
  • products of oncogenic viruses (EBV and HPV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe tumor associated antigens

A
  • not necessarily unique to tumors
  • overexpressed by tumors: Her2-Neu
  • tumor-specific post-translational modificications, Muc-1 abnormal glycosylation and localization
17
Q

describe cancer/testis antigens

A

tumor associated antigens
- expression restricted to gametogenic tissues (immunologically privileged) and cancer
- genes frequently map to chromosome X (50%)
- immunogenic in cancer patients
- expression may be related to tumor progression and with tumors of high metastatic potential

18
Q

describe tumors and their immunogenic-ness

A

tumors may not be very immunogenic
- chemical or radiation-induced tumors as well as virally-induced tumors are generally immunogenic b/c of the generation of altered self
- however, many spontaneous tumors may not be very immunogenic
- an immune response against a self-antigen generally requires breaking self-tolerance

19
Q

describe immune evasion by tumors (best & worst case scenarios)

A

best-case scenario: tumor cell- has tumor specific antigens that can be recognized by MHC—> activation of T cell response

bad: tumor cell may not express tumor specific antigens, or MHC class I or they may express inhibitory ligands and immunosuppressive cytokines—> inhibition of T cell activation

20
Q

mechanisms of tumor-mediated immune suppression

A

secreted factors: IL-10, TGF-B, PGE-2 (all decrease the potency of anti-tumor effector cells)

  • tumors can provide negative costimulation:
    CTLA-4/B-7 inteactions
    PD-1/PDL1 interactions
    downregulation of MHC
21
Q

TGF-B positively regulates ___

A

Treg cells —> immunosuppressant

22
Q

more mechanisms of tumor-mediated immune suppression

A
  • T regulatory cells
  • CD4+ and CD25low and/or Foxp3-Tregs
  • suppressive activity mediated through secreted factors IL-10 and TGF-B
  • in vivo depletion of Tregs through anti-CD25 treatment slowed the growth of transplantable tumors in syngeneic mice
23
Q

mechanisms of tumor defense

A
  • innate immunity- Nk cells, macrophages, DC’s
  • adaptive immunity- CD4+ and CD8+ T cells, more limited role for B cells
24
Q

NK cells and cancer

A
  • mice lacking NK cells have faster growing tumors
  • tumor cells that lack MHC molecules are sensitive to NK-mediated killing
  • tumors can express ligands that activate NK-mediated killing
  • NK cells express IFN-y and TNF-a which can inhibit tumor growth
25
Q

opportunities for immunotherapy

A

often, primary tumors are not eliminated by immune therapy alone
- after surgery and radiation, opportunities to fight metastases or silent tumors with immune therapy
- need to wait for restoration of immune system following certain chemo therapies

26
Q

cell-based immunotherapy for tumors, cell transfer

A

tumor-bearing patient- isolate lymphocytes from blood or tumor infiltrate
- expand in culture with IL-2 may be transfected with CAR gene
- transfer back into patient –> tumor regression

27
Q

monoclonal antibody therapy

A

monoclonal antibody directed against certain antigens expressed by tumor cells
- ex: CD20 antibody can be linked to a toxin, antibody homes to tumor and delivers toxin, leads to its destruction